Business / Finance

RSS

RBMG selects Dynatronics for inclusion in the RB Milestone Portfolio

Dynatronics Corporation announced that it has been selected for inclusion in the RB Milestone Portfolio, a group of companies selected by RB Milestone Group, LLC, to be introduced to the market via a combination of traditional and innovative analytical and communication strategies including equity research, The Portal Network, and non-deal roadshows, with a focus on the healthcare, mining, energy, and technology sectors.

17 Mar 2011

Leading cancer center to acquire GammaMed brachytherapy from Varian

Cancer patients in China will gain access to Varian's state-of-the-art cancer care with the announcement that a leading cancer center is acquiring a GammaMed brachytherapy afterloader from Varian Medical Systems.

17 Mar 2011

Lantheus proposes $150 million 9.750% Senior Notes offering

Lantheus Medical Imaging, Inc. today announced that it intends to offer $150 million in aggregate principal amount of its 9.750% Senior Notes due 2017 (the "New Notes"). The New Notes are being offered as additional debt securities under an indenture pursuant to which Lantheus previously issued $250 million in aggregate principal amount of 9.750% Senior Notes due 2017.

16 Mar 2011

PHC announces acquisition of MeadowWood Behavioral Health

PHC, Inc., d/b/a Pioneer Behavioral Health, a leading provider of inpatient and outpatient behavioral health services, today announced that it has signed an agreement to acquire MeadowWood Behavioral Health, located in New Castle, Delaware, for $21.5 million, subject to customary purchase price adjustments. The transaction is expected to close late in the second quarter of 2011.

16 Mar 2011

Cortex enters agreement with Biovail to regain AMPAKINE assets and rights

Cortex Pharmaceuticals, Inc. announced that it has entered into an agreement with Biovail Laboratories International SRL, a wholly-owned subsidiary of Valeant Pharmaceuticals International, Inc., to regain the AMPAKINE® assets and rights related to respiratory depression.

16 Mar 2011

TSO3 revenue decreases to $7.7 million for fiscal year ending December 31, 2010

TSO3 Inc. an innovator in sterilization technology for medical devices in healthcare settings using ozone, today reported sales for the fiscal year ending December 31, 2010 totalling $939,285 representing the sale of four new generation sterilizers to 3M for training purposes.

16 Mar 2011

Prism Medical receives new UK contract to provide Disability Equipment Services

Prism Medical Ltd., a leading provider of durable medical equipment and related services to the mobility disadvantaged, today announced that the Company has been awarded a significant new contract to provide Disability Equipment Services for the London Borough of Bexley.

16 Mar 2011

China Nepstar Chain Drugstore fourth quarter revenues increase 1.0% to US$95 million

China Nepstar Chain Drugstore Ltd., the largest retail drugstore chain in China based on the number of directly operated stores, today announced its unaudited financial results for the fourth quarter and fiscal year ended December 31, 2010.

16 Mar 2011

Almac invests in two ZED automated inline wallet presses

Global Clinical Services provider Almac has announced an investment in two ZED automated inline wallet presses. Operating in Craigavon and Pennsylvania, the fully automated machines will drastically reduce timelines associated with the use of blister card packaging, when compared with current rotary press methods.

16 Mar 2011

Sonova expects sales of around CHF 1,600 million for the current business year 2010/11

Sonova Holding AG, the world's leading provider of hearing systems, is announcing today that the Group is expecting sales of around CHF 1,600 million and an EBITA margin of 20-21% for 2010/11, barring any unforeseen events.

16 Mar 2011

Wound Management reviews alternatives to return to OTCBB

Wound Management Technologies, Inc., a leader in advanced wound care solutions, today commented on the shift in the Company's stock quotation coverage which recently transitioned from the OTCBB to the OTCQB under the symbol "WNDM."

16 Mar 2011

NMS announces license agreement with Novartis

Nerviano Medical Sciences, the largest pharmaceutical R&D facility in Italy and one of the leading oncology-focused, integrated discovery and development companies in Europe, today announced a license agreement with Novartis.

16 Mar 2011

Raymond Associates, BioNeutral enter global sales and distribution agreement for Ygiene antimicrobial technology

BioNeutral Group, Inc., a specialty life science technology-based company, today announced that it has entered into a global sales and distribution agreement with Raymond Associates LLC, a Service Connected Certified Disabled Veteran-Owned Business and executive management consulting firm.

15 Mar 2011

Omeros fourth quarter net loss increases to $7.2 million

Omeros Corporation, a biopharmaceutical company committed to discovering, developing and commercializing products focused on inflammation, bleeding and disorders of the central nervous system, today announced financial results for the fourth quarter and year ended December 31, 2010.

15 Mar 2011

DJO Global signs definitive agreement to purchase Rikco for $254.6 million

DJO Global, Inc., a leading provider of medical device solutions for musculoskeletal health, vascular health and pain management, today announced that one of its indirect subsidiaries has signed a definitive agreement to purchase Rikco International, LLC, D/B/A Dr. Comfort, for approximately $254.6 million in cash.

15 Mar 2011

BioDrain retains CFSG1 as its U.S. Investor Relations representative

BioDrain Medical, Inc., producer of the FDA cleared Streamway System for automated surgical fluid disposal, announced today that it has retained Consulting for Strategic Growth 1 as its U.S. Investor Relations representative.

15 Mar 2011

ShangPharma fourth quarter net revenues increase 29.4% to $25.6 million

ShangPharma Corporation, a leading China-based pharmaceutical and biotechnology research and development outsourcing company, today announced its financial results for its fourth quarter and the fiscal year ended December 31, 2010.

15 Mar 2011

Illumina prices 0.25% Convertible Senior Notes due 2016

Illumina, Inc. today announced the pricing of $800 million principal amount of 0.25% Convertible Senior Notes due 2016 through offerings to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.

From Illumina, Inc. 15 Mar 2011

Medidata fourth quarter net revenue is $47.4 million for 2010

Medidata Solutions, a leading global provider of SaaS-based clinical technology solutions that enhance the efficiency of clinical development, today announced its financial results for the fourth quarter 2010 and full year ended December 31, 2010, as well as provided financial guidance for the first quarter and full year 2011.

15 Mar 2011

Hanger Orthopedic Group amends existing Credit Agreement

Hanger Orthopedic Group, Inc. announced today that it has amended its existing Credit Agreement to lower the applicable interest rates and modify certain other covenants. The Amendment (i) reduces the interest rate margin applicable to the term loan under the Credit Agreement by 0.75% to 3.00% and (ii) reduces the LIBOR floor applicable to the term loan under the Credit Agreement from 1.50% to 1.00%.

14 Mar 2011